# Risk_factors_for_severe_COVID19_outcomes_a_study_of_IMIDs_medications_comorbidities
This contains the code used to conduct the analyses for Qi et al. 2022 paper on the analysis of Risk factors for severe COVID-19 outcomes: a study of immune-mediated inflammatory diseases, immunomodulatory medications, and comorbidities in a large US healthcare system
